PremiumThe FlyFuture Pak submits proposals to acquire Theratechnologies Theratechnologies Reports Strong Q1 2025 Growth Theratechnologies’ Earnings Call: Growth Amid Challenges PremiumThe FlyTheratechnologies receives FDA approval of PAS for EGRIFTA SV sBLA THTX Earnings this Week: How Will it Perform? Theratechnologies Gains FDA Approval for New Tesamorelin Formulation PremiumCompany AnnouncementsTheratechnologies’ Earnings Call: Growth Amid Challenges Theratechnologies Reports Strong Fiscal 2024 Performance Theratechnologies Achieves Record Financial Results and Secures Future Growth